Secures Non-Dilutive Grant From Hessian Ministry of Economics to Develop Digital BiomarkersPosted by On

Peer reviewed grant will support company’s vision to develop compassionate AI for mental health conditions

An early validation of our mission to develop compassionate AI that is at the service of humanity and to democratize access to mental health care…”

— Dr. Peter O. Owotoki, Co-Founder and CEO

KRONBERG, HESSE, GERMANY, October 15, 2020 / —, a German Medtech start-up and leader in the compassionate Artificial Intelligence (AI) field, announces today that it is a recipient of a non-dilutive grant from the Hessian Ministry of Economics. The grant is financed by the European Regional Development Fund (ERDF). The Peer-Reviewed grant will cover 45% of R&D costs of, until the end of 2022, to develop its first digital Biomarker for Autism Spectrum Disorders (ASD).

Autism is a complex neurodevelopmental disorder that is characterized by social, communication, learning, and…

Original Author Link click here to read complete story..



Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.